$0.00$0.00 (0.0%)
Healthcare Solutions Management Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
OTC · CEVE · USD
Stock price
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Ceres Ventures, Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
Ceres Ventures, Inc. is an emerging clean technology firm dedicated to developing and bringing to market innovative environmental solutions aimed at purifying contaminated water, soil, and air. The company's core technological offerings comprise: BluFlow Nanoparticles: A proprietary system that engineers and deploys tailor-made absorbent nanoparticles. These microscopic particles are designed to precisely capture and remove various contaminants and chemicals, and can also be utilized to recover valuable elements and compounds from aquatic environments. BluFlow Advanced Ultrafiltration Technology: An automated ultrafiltration process focused on reclaiming clean water from industrial waste streams and other impure liquid sources. The BluFlow Treatment System, which integrates both the Nanoparticle and Advanced Ultrafiltration technologies. This comprehensive solution effectively eliminates a broad spectrum of pollutants, compounds, and undesirable elements, rendering water sufficiently pure for potential reuse. These solutions find diverse applications, including municipal and industrial water and wastewater purification, remediation of tainted groundwater, and the extraction of valuable resources from various solutions. Previously operating as PhytoMedical Technologies, Inc., the company adopted its current name, Ceres Ventures, Inc., in November 2011. Its headquarters are located in New York, New York.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
Healthcare Solutions Management Group, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
ViewRay, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Stem Cell Authority, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 98.67% below the high.
$0.00$0.00 (0.0%)
Scopus BioPharma Inc.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
$0.00$0.00 (0.0%)
Natural Health Farm Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
RenovaCare, Inc.’s quoted price sits in the lower half of its reported 52-week range, 90.0% below the high.
$0.00$0.00 (0.0%)
Medite Cancer Diagnostics, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
American Scientific Resources, Incorporated’s quoted price sits in the lower half of its reported 52-week range, 70.0% below the high.